Biotechnology
Biotechnology prior art search
Search prior art for biotechnology inventions: sequences, vectors, assays, diagnostics, and recombinant methods.
Related biotechnology patents
- Board Of Regents, The University Of Texas SystemPublished 2023-01-10
A computer-implemented method of training a neural network to improve a characteristic of a protein comprises collecting a set of amino acid sequences from a database, compiling each amino acid sequence into a three-dimensional crystallographic structure of a folded protein, training a neural …
- ザ・ブロード・インスティテュート・インコーポレイテッドPublished 2026-04-17
An engineered CRISPR-Cas9 chimeric RNA containing the following nucleotide sequence: NNNNNNNNNNNNNNNNNNNNNNNNGUUUUUAGAGCUAGAAAUAGCAAGUUAAAAAAAUAGGCUAGUCCGUUAUCA. An engineered CRISPR-Cas9 chimeric RNA containing the following nucleotide sequence: …
- ロシュ グリクアート アクチェンゲゼルシャフトPublished 2018-05-23
The present invention provides a method for generating a host cell that produces a recombinant antibody with enhanced Fc-mediated cellular cytotoxicity, comprising: providing a host cell that is capable of expressing a recombinant antibody comprising an IgG Fc region containing N-linked …
- The Regents of the University of CaliforniaPublished 2025-02-26
A single-molecule DNA-targeting RNA which binds to a site-directed modifying polypeptide and targets said site-directed modifying polypeptide to a specific location within a target DNA, wherein said single-molecule DNA-targeting RNA comprises: (a) a DNA-targeting segment comprising a nucleotide …
- ザ・ブロード・インスティテュート・インコーポレイテッドPublished 2020-07-15
An engineered, non-naturally occurring, clustered, equidistant, short-chain batch repeat (CRISPR)-CRISPR-related (Cas) (CRISPR-Cas) vector system, a) a first regulatory operably linked to one or more nucleotide sequences encoding one or more CRISPR-Cas system guide RNAs that hybridize to a target …
- ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニアPublished 2024-02-01
A pharmaceutical composition for treating a hematological malignancy in a human patient comprising a human T cell comprising a nucleic acid sequence encoding a chimeric antigen receptor (CAR), the composition comprising: The CAR comprises a CD19 antigen-binding domain comprising the amino acid …
- Gen9, Inc.Published 2021-04-20
Methods and devices are provided for preparing a protein array having a plurality of proteins. In one embodiment, the method includes providing a plurality of nucleic acids each having a predefined sequence and expressing in vitro a plurality of proteins from the plurality of nucleic acids. In …
- Roche Glycart AgPublished 2024-09-12
1 . An isolated polynucleotide comprising a. a sequence selected from the group consisting of: SEQ ID NO.: 5, SEQ ID NO.: 6 and SEQ ID NO: 7; and b. a sequence selected from the group consisting of SEQ ID NO: 21, SEQ ID NO: 22 and SEQ ID NO: 23; and c. sequence ID NO: 24. 2 - 259 . (canceled)
Search your own biotechnology idea
Describe your invention in plain language with its key technical features. Persoona queries Google Patents and ranks the closest results.
Why a prior art search matters for biotechnology
Biotech claims are dense and heavily litigated, so an early prior-art read protects years of research investment. It also surfaces the closest sequences and methods you will need to distinguish.
- Isolated natural products and correlations face eligibility limits after Myriad and Mayo; the inventive step usually has to be in a made or applied thing.
- Sequence listings and prior publications are frequently the closest art, not just patents.
- Enablement and written description are demanding for genus claims.